Toxic Adenoma echocardiography and ultrasound

Jump to navigation Jump to search

Toxic Adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:T On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic Adenoma echocardiography and ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic Adenoma echocardiography and ultrasound

CDC on Toxic Adenoma echocardiography and ultrasound

Toxic Adenoma echocardiography and ultrasound in the news

Blogs on Toxic Adenoma echocardiography and ultrasound

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Toxic Adenoma echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Ultrasound is indicated only when adenoma presents as a nonpalpable nodule. Ultrasonography is helpful when correlated with nuclear scans to determine the functionality of nodules. Dominant cold nodules should be considered for fine-needle aspiration biopsy prior to definitive treatment of a toxic nodular goiter.

Ultrasound Findings

Ultrasound is indicated only when adenoma presents as a nonpalpable nodule. Ultrasonography is helpful when correlated with nuclear scans to determine the functionality of nodules. Dominant cold nodules should be considered for fine-needle aspiration biopsy prior to definitive treatment of a toxic nodular goiter.[1]

References

  1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016). "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer". Thyroid. 26 (1): 1–133. doi:10.1089/thy.2015.0020. PMC 4739132. PMID 26462967.